Biomedical Research
Why Costa Rica as Clinical trials Destination
Good Clinical Infrastructure and Proven Quality of Clinical Studies. Costa Rica accounts with excellent medical professionals and internationally accredited institutions (JCI accredited hospital). Costa Rica was ranked 36 (WHO) among best healthcare systems in the world
Easy access to patients. The fact that most Costa Ricans live within large urban areas means that recruitment efforts can be concentrated and trials’ logistics gets simplified.
Willing and compliant patients. Costa Ricans are, generally, eager to participate in clinical trials when their physicians recommend doing so.
Season inversion from the Northern Hemisphere. By extending studies into Latin America, sponsor companies can pursue year-round research on conditions that are tied to seasons (such as pneumonia, the flu, and allergies for example).
Proximity to North America. The country´s time zone is convenient for interactions with headquarter offices of North American R&D companies.
Excellent regulatory timelines for study start up (5 to 10 weeks)
Easy access to a diverse patient population.
Epidemiologic profile: similar to developed countries
Find out about clinical trials studies developed in Costa Rica
Expected Regulatory Timelimes for Study Start ups (weeks/calendar)